VCEL Q3 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+30.5% YoY

Gross Profit

$7M49.6% margin

Operating Income

-$4M-28.3% margin

Net Income

-$5M-37.9% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-15.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$755,000

Balance Sheet

Total Assets

$40M

Total Liabilities

$24M

Stockholders' Equity

$17M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$11M	+30.5%
Gross Profit	$7M	$4M	+73.7%
Operating Income	-$4M	-$6M	+36.8%
Net Income	-$5M	-$7M	+19.0%